Essay
Now that small molecular-level deletions and subtle chromosomal rearrangements can be discovered using advanced cytogenetic techniques and microarrays,disorders whose causes had not previously been known can have their basis identified.However,since most of these are not widely publicized,being individually rare,it has been difficult to identify patients with shared chromosomal abnormalities who share phenotypic features.A new database,known as DECIPHER,is now available to search for patients with like phenotypes and/or like chromosomal abnormalities.If you are the clinical geneticist who has a patient whose data is entered into this database,suggest three or more ways in which this could be useful either to you or to the patient.
Correct Answer:

Verified
Many patients suffering from rare disord...View Answer
Unlock this answer now
Get Access to more Verified Answers free of charge
Correct Answer:
Verified
View Answer
Unlock this answer now
Get Access to more Verified Answers free of charge
Q6: A genome sequence is considered to be
Q12: Often, in the absence of experimental data,
Q25: Transcomplementation is a name sometimes given for
Q28: A report of a newly identified syndrome
Q31: In looking for a gene responsible for
Q32: If an entire genome is fragmented and
Q35: The whole-genome shotgun approach (WGS)was first used
Q48: Scientists studying the causes of a type
Q51: Recombination between two Alu elements results in
Q52: If a gene product is not a